KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Amortization - Intangibles: 2017-2023

Historic Amortization - Intangibles for BeOne Medicines (ONC) over the last 7 years, with Dec 2023 value amounting to $7.2 million.

  • BeOne Medicines' Amortization - Intangibles rose 14.49% to $1.2 million in Q2 2024 from the same period last year, while for Jun 2024 it was $7.6 million, marking a year-over-year increase of 91.06%. This contributed to the annual value of $7.2 million for FY2023, which is 82.07% up from last year.
  • Per BeOne Medicines' latest filing, its Amortization - Intangibles stood at $7.2 million for FY2023, which was up 82.07% from $4.0 million recorded in FY2022.
  • Over the past 5 years, BeOne Medicines' Amortization - Intangibles peaked at $7.2 million during FY2023, and registered a low of $846,000 during FY2020.
  • Over the past 3 years, BeOne Medicines' median Amortization - Intangibles value was $4.0 million (recorded in 2022), while the average stood at $4.3 million.
  • Per our database at Business Quant, BeOne Medicines' Amortization - Intangibles crashed by 36.20% in 2020 and then spiked by 131.84% in 2022.
  • Yearly analysis of 5 years shows BeOne Medicines' Amortization - Intangibles stood at $1.3 million in 2019, then slumped by 36.20% to $846,000 in 2020, then spiked by 102.72% to $1.7 million in 2021, then surged by 131.84% to $4.0 million in 2022, then spiked by 82.07% to $7.2 million in 2023.